Global Metabolic Biomarker Testing Market Research Report 2023

Publication ID:

PB502233385

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
Highlights
The global Metabolic Biomarker Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metabolic Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Biomarker Testing.
The Metabolic Biomarker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Metabolic Biomarker Testing market comprehensively. Regional market sizes, concerning products by technology, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolic Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by technology, by application, and by regions.
By Company
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Segment by Technology
Separation Techniques
Detection Techniques
Others
Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by technology, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolic Biomarker Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2018 VS 2022 VS 2029
1.2.2 Separation Techniques
1.2.3 Detection Techniques
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metabolic Biomarker Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Biomarker Testing Market Perspective (2018-2029)
2.2 Metabolic Biomarker Testing Growth Trends by Region
2.2.1 Global Metabolic Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Metabolic Biomarker Testing Historic Market Size by Region (2018-2023)
2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Region (2024-2029)
2.3 Metabolic Biomarker Testing Market Dynamics
2.3.1 Metabolic Biomarker Testing Industry Trends
2.3.2 Metabolic Biomarker Testing Market Drivers
2.3.3 Metabolic Biomarker Testing Market Challenges
2.3.4 Metabolic Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Biomarker Testing Players by Revenue
3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2018-2023)
3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2018-2023)
3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue
3.4 Global Metabolic Biomarker Testing Market Concentration Ratio
3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2022
3.5 Metabolic Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Metabolic Biomarker Testing Product Solution and Service
3.7 Date of Enter into Metabolic Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Biomarker Testing Breakdown Data by Technology
4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2018-2023)
4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2024-2029)
5 Metabolic Biomarker Testing Breakdown Data by Application
5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2018-2023)
5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Metabolic Biomarker Testing Market Size (2018-2029)
6.2 North America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Metabolic Biomarker Testing Market Size by Country (2018-2023)
6.4 North America Metabolic Biomarker Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolic Biomarker Testing Market Size (2018-2029)
7.2 Europe Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Metabolic Biomarker Testing Market Size by Country (2018-2023)
7.4 Europe Metabolic Biomarker Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2018-2029)
8.2 Asia-Pacific Metabolic Biomarker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolic Biomarker Testing Market Size (2018-2029)
9.2 Latin America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Metabolic Biomarker Testing Market Size by Country (2018-2023)
9.4 Latin America Metabolic Biomarker Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2018-2029)
10.2 Middle East & Africa Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Bruker
11.3.1 Bruker Company Detail
11.3.2 Bruker Business Overview
11.3.3 Bruker Metabolic Biomarker Testing Introduction
11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.3.5 Bruker Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Metabolic Biomarker Testing Introduction
11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 Waters Corporation
11.5.1 Waters Corporation Company Detail
11.5.2 Waters Corporation Business Overview
11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction
11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.5.5 Waters Corporation Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Biocrates Life Sciences
11.7.1 Biocrates Life Sciences Company Detail
11.7.2 Biocrates Life Sciences Business Overview
11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction
11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.7.5 Biocrates Life Sciences Recent Development
11.8 Human Metabolome Technologies
11.8.1 Human Metabolome Technologies Company Detail
11.8.2 Human Metabolome Technologies Business Overview
11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction
11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.8.5 Human Metabolome Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂